Vascular Medicine

  • The role of SGLT-2 inhibitors in managing type 2 diabetes
    Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

    These drugs improve glycemic control and offer cardiovascular and metabolic benefits.

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

  • In Reply: COVID-19 coagulopathy
    Simon R. Mucha, MD, Siddharth Dugar, MD, Keith McCrae, MD, Douglas Joseph, DO, John Bartholomew, MD, Gretchen L. Sacha, PharmD, RPh, BCCCP and Michael Militello, PharmD, RPh, BCPS
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/cjm.87c.12002

    An attempt to balance the potential risks and benefits of intensified prophylaxis.

  • Air embolism after peripheral IV contrast injection
    Justin Goodwin, MS and Karthik Gnanapandithan, MD, MS, FHM
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 718-720; DOI: https://doi.org/10.3949/ccjm.87a.20001

    As little as 2 to 3 mL of air in the cerebral circulation can be fatal.

  • Optimal surveillance and treatment of renal and splenic artery aneurysms
    Optimal surveillance and treatment of renal and splenic artery aneurysms
    CME article
    Tom Kai Ming Wang, MBCHB, MD(res), FRACP and Milind Y. Desai, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 755-758; DOI: https://doi.org/10.3949/ccjm.87a.19140-2

    Indications for repair are based on aneurysm location and risk factors for rupture.

  • A sneaky vascular disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 581-582; DOI: https://doi.org/10.3949/ccjm.87b.10020

    Cholesterol embolization syndrome may provide insights into atherosclerotic disease.

  • Trousseau sign and syndrome: Erroneous terms
    Steven Yale, MD, MACP, Halil Tekiner, PhD, Joseph Mazza, MD and Eileen Scott Yale, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 585; DOI: https://doi.org/10.3949/ccjm.87c.10002

    Trousseau never described a constellation of symptoms in this disease.

  • In Reply: Trousseau sign and syndrome: Erroneous terms
    Satish S. Maharaj, MD, Michael Omar, MBBS, Karan Seegobin, MBBS and Simone Chang, MBBS
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 586; DOI: https://doi.org/10.3949/ccjm.87c.10003

    Trousseau sign should continue to be taught and recognized on physical examination.

  • When is contrast needed for abdominal and pelvic CT?
    Mark Radetic, MD, Robert DeVita, MD and John Haaga, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 595-598; DOI: https://doi.org/10.3949/ccjm.87a.19093

    The decision to use contrast depends on the diagnosis suspected.

  • Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
    Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115

    Triple therapy is aggressive and carries high risks of bleeding and death.

Pages